Ibex Medical Analytics deploys advanced solution at Maccabi pathology institute to support accurate diagnosis

US becomes first country to officially endorse shot; hundreds of millions of doses administered since emergency rollout in December

Authorities plan to begin administering 3rd doses to Americans in September, saying it's 'very clear' vaccines are less effective at preventing infection over time

FDA says authorization applies to several million Americans who are vulnerable because of organ transplants, some cancers or other disorders; not yet for general population

Final okay could boost vaccine-hesitant people's confidence in getting the shot

Pfizer says trial results for those aged 5-11 likely in by September; company seeking full approval, as some are hesitant due to emergency use authorization

Israel moving ahead with issuing 3rd dose to the immunocompromised; CDC and FDA say extra vaccine unnecessary 'at this time'

Bid to get OK comes even as studies indicate that two-dose regimen still protects and many places continue to struggle to get first shot to people

Designation is 'important step' toward startup Ibex Medical Analytics making its software available in US

Wegovy is a higher-dose version of Novo Nordisk’s diabetes drug semaglutide and studies show participants had average weight loss of 34 pounds, lost weight steadily for 14 months